References
Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453–68.
Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591–602.
Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384(4):305–15.
Walters TE, Nisbet A, Morris GM, et al. Progression of atrial remodeling in patients with high-burden atrial fibrillation: implications for early ablative intervention. Heart Rhythm. 2016;13(2):331–9.
Andrade JG, Wazni OM, Kuniss M, et al. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(9):914–30.
Proietti R, Hadjis A, AlTurki A, et al. A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter ablation. JACC Clin Electrophysiol. 2015;1(3):105–15.
Baysal E, Oksul M, Burak C, et al. Decreasing time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation positively affects long-term consequences. J Interv Card Electrophysiol. 2022.
Chew DS, Jones KA, Loring Z, et al. Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation. Heart Rhythm O2. 2022;3(1):23–31.
Bunch TJ, May HT, Bair TL, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart Rhythm. 2013;10(9):1257–62.
Andrade JG, Deyell MW, Verma A, et al. Association of atrial fibrillation episode duration with arrhythmia recurrence following ablation: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3(7):e208748.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. JG Andrade reports grants and personal fees from Medtronic, grants from Baylis, personal fees from Biosense-Webster. Dr. M. Deyell reports honoraria and research funding from Biosense Webster, and honoraria from Medtronic, Abbott and Boston Scientific.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1007/s10840-022-01167-3.
Rights and permissions
About this article
Cite this article
Andrade, J.G., Deyell, M.W. AF ablation: you cannot escape the responsibility of tomorrow by evading it today. J Interv Card Electrophysiol 65, 341–342 (2022). https://doi.org/10.1007/s10840-022-01257-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01257-2